SBI Securities’s Nuvation Bio NUVB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$9.38K Buy
1,675
+293
+21% +$1.84K ﹤0.01% 1876
2026
Q2
$7.85K Buy
1,382
+354
+34% +$1.73K ﹤0.01% 1955
2026
Q1
$4.41K Buy
1,028
+7
+0.7% +$39 ﹤0.01% 2083
2025
Q4
$9.15K Buy
1,021
+2
+0.2% +$12 ﹤0.01% 1746
2025
Q3
$3.77K Buy
1,019
+817
+404% +$2.23K ﹤0.01% 2165
2025
Q2
$394 Buy
202
+201
+20,100% +$419 ﹤0.01% 3062
2025
Q1
$2 Hold
1
– – ﹤0.01% 4094
2024
Q4
$3 Buy
+1
New +$3 ﹤0.01% 4040

Other funds holding NUVB

SBI Securities's NUVB Position: Q3 2026 in Review

SBI Securities increased its Nuvation Bio (NUVB) stake by 21% in Q3 2026, buying an estimated $1.84K and bringing the position to 1,675 shares worth $9.38K. The position accounts for ﹤0.01% of the portfolio, ranked #1876.

SBI Securities first reported a position in NUVB in Q4 2024 and has held it in 8 quarters since. 93 funds tracked by Wall St. Rank hold NUVB as of Q3 2026.

  • SBI Securities held 1,675 shares of Nuvation Bio worth $9.38K as of Q3 2026.
  • SBI Securities bought 293 Nuvation Bio shares in Q3 2026, an estimated $1.84K.
  • Nuvation Bio made up ﹤0.01% of SBI Securities's portfolio in Q3 2026, its #1876 holding.
  • SBI Securities first reported a position in Nuvation Bio in Q4 2024 and has held it in 8 quarters since.
  • 93 funds tracked by Wall St. Rank held Nuvation Bio as of Q3 2026.

Based on SBI Securities's 13F filing for Q3 2026, filed 22 Oct 2026.